| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 阳景 | 浦银国际证券 | 医药生物 | 26.90% | 40.74% | 1.68% | 100.00% | 4 | 0.00% | 2025-05-23 |
| 2 | 阳景 | 浦银国际证券 | 医药生物 | 26.88% | 61.14% | 25.17% | 100.00% | 2 | 0.00% | 2025-03-20 |
| 3 | 吴春红 | 江海证券 | 医药生物 | 26.86% | 21.11% | 13.79% | 27.27% | 6 | -25.67% | 2025-06-23 |
| 4 | 仰佳佳 | 申万宏源 | 医药生物 | 26.86% | 29.23% | 25.09% | 23.08% | 1 | -37.64% | 2025-05-07 |
| 5 | 王班 | 民生证券 | 医药生物 | 26.84% | 32.24% | 25.57% | -21.43% | 15 | -61.25% | 2025-07-16 |
| 6 | 袁聪敏 | 中信证券 | 医药生物 | 26.82% | 20.69% | 31.66% | 100.00% | 5 | 0.00% | 2025-04-11 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 26.81% | 29.65% | 25.04% | 23.08% | 1 | -37.64% | 2025-05-08 |
| 8 | 张林晚 | 上海证券 | 医药生物 | 26.77% | 19.32% | 15.96% | -100.00% | 1 | -18.93% | 2025-06-19 |
| 9 | 吴春红 | 江海证券 | 医药生物 | 26.67% | 7.96% | 27.25% | 27.27% | 10 | -25.67% | 2025-05-06 |
| 10 | 王斌 | 首创证券 | 医药生物 | 26.62% | 29.77% | 18.28% | 4.11% | 20 | -54.62% | 2025-07-14 |
| 11 | 武煜 | 招银国际 | 医药生物 | 26.59% | 13.97% | 24.23% | -33.33% | 2 | -16.66% | 2025-05-12 |
| 12 | 周豫 | 太平洋 | 医药生物 | 26.58% | 29.95% | 11.58% | 21.21% | 23 | -55.62% | 2025-07-03 |
| 13 | 阳景 | 浦银国际证券 | 医药生物 | 26.58% | 46.57% | 27.16% | 100.00% | 2 | 0.00% | 2025-03-27 |
| 14 | 夏禹 | 国联民生 | 医药生物 | 26.56% | 22.76% | 25.77% | 20.00% | 7 | -52.01% | 2025-04-22 |
| 15 | 武煜 | 招银国际 | 医药生物 | 26.54% | 14.41% | 26.35% | -33.33% | 2 | -16.66% | 2025-05-13 |
| 16 | 夏禹 | 国联民生 | 医药生物 | 26.51% | 9.98% | 10.38% | 20.00% | 8 | -52.01% | 2022-12-30 |
| 17 | 王班 | 民生证券 | 医药生物 | 26.49% | 33.94% | 23.54% | -21.43% | 15 | -61.25% | 2025-07-11 |
| 18 | 张林晚 | 上海证券 | 医药生物 | 26.49% | 14.43% | 25.20% | -100.00% | 1 | -18.93% | 2025-05-29 |
| 19 | 袁聪敏 | 中信证券 | 医药生物 | 26.45% | 19.00% | 16.15% | 100.00% | 1 | 0.00% | 2025-05-07 |
| 20 | 周豫 | 太平洋 | 医药生物 | 26.44% | 20.26% | 18.30% | 21.21% | 23 | -55.62% | 2025-06-13 |